BEX Capital is a pioneering private equity secondaries investment firm with over $500 million in assets under management.
Founded in 2010, BEX Capital is the leading buyer of limited partnership interests in fund-of-funds, secondary funds and co-investment funds. Our unique investment strategy allows us to deliver superior, risk-adjusted returns to investors.
We make individual investments ranging from $1 million to $500 million. At the larger end of this scale, BEX Capital can draw on support from its core group of investors.
Founded in 2010, BEX Capital is the leading buyer of limited partnership interests in fund-of-funds, secondary funds and co-investment funds. Our unique investment strategy allows us to deliver superior, risk-adjusted returns to investors.
We make individual investments ranging from $1 million to $500 million. At the larger end of this scale, BEX Capital can draw on support from its core group of investors.
Location: France, Provence-Alpes-Côte d'Azur, Nice
Employees: 11-50
Phone:602752
Founded date: 2010
Mentions in press and media 6
| Date | Title | Description |
| 16.04.2025 | Sagard Announces Strategic Partnership with BEX Capital to Strengthen Private Equity Secondaries Offering | Following this strategic partnership with a secondaries platform, Sagard now offers a full suite of private equity solutions and expands its global investment footprint MONTREAL and NICE, France, April 16, 2025 /PRNewswire/ -- Sagard, a glo... |
| 10.09.2024 | BEX Capital Closes BEX Fund V, at $765M | BEX Capital, a Nice, France- and NYC-based investment firm focused exclusively on secondaries in private equity fund-of-funds (FoF), secondaries funds and co-investment funds, closed BEX Fund V, at $765M. As with its predecessors, Fund V is... |
| 17.03.2022 | As interest rates rise, will limited partners move on from venture capital? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Time to climb. Paid Content A woman leader shares her advice for the next generation From Infosys... |
| 16.04.2019 | Why Startups Marketing Prescription Drugs Need to Tread Carefully: Term Sheet for Tuesday, April 16 | TREAD CAREFULLY Ro, a direct-to-consumer telehealth business, is raising another round of funding. According to TechCrunch, the company is raising $85 million in Series B funding at a $500 million valuation. It’s unclear who participated in... |
| 10.04.2019 | BEX Capital Raises $365M Fund-of-Funds | BEX Capital, a Nice, France – based investment firm focused exclusively on fund-of-funds (FoF) secondaries, closed BEX Fund III, with total commitments of $365m. This was the first and final close of BEX Fund III, with fundraising completed... |
| 19.09.2017 | Term Sheet — Tuesday, September 19 | VCs VERSUS ICOs Companies have raised more than $1.7 billion through initial coin offerings this year, surpassing early-stage VC funding for Internet companies. It’s easy to see why an ICO is appealing to tech founders (No due diligence! LO... |